Talha Munir

Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma

Talha Munir, Jennifer R. Brown, Susan O’Brien et al. · American Journal of Hematology · 2019 · 451 citations · Full text

Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma

Michael Wang, Wojciech Jurczak, Pier Luigi Zinzani et al. · Journal of Clinical Oncology · 2023 · 89 citations · Full text

Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study

Talha Munir, Carol Moreno, Carolyn Owen et al. · Journal of Clinical Oncology · 2023 · 39 citations · Full text

Real‐world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria

Morag Griffin, Richard Kelly, Isabelle Brindel et al. · American Journal of Hematology · 2024 · 33 citations · Full text

The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò et al. · American Journal of Hematology · 2023 · 21 citations · Full text